Upcoming Webinars and a Roundup of New Resources
View this email in your browser ([link removed])
[link removed] June 28, 2024
** Upcoming Webinars and a Roundup of New Resources
------------------------------------------------------------
Dear Advocate,
Last week’s interim result of the PURPOSE 1 HIV prevention study ([link removed]) of injectable lenacapavir is captivating headlines. Check out AVAC’s statement here ([link removed]) and one from the PURPOSE 1 Global Community Accountability Board and the African Women’s Prevention Community Accountability Board here ([link removed]) . But there are LOTS of other things also happening in HIV prevention, and we’re delighted to share this roundup.
Upcoming Webinars
WEBINAR
Tuesday, July 9, 9:00AM ET
[link removed]
** Responding to Project 2025’s Threats to Science, Rights and Resources ([link removed])
------------------------------------------------------------
Project 2025 is part of an ongoing multi-pronged backlash to the sexual and reproductive health, gender and LGBTQ+ movements. Building on the experience of the HIV movement in fighting these same far-right forces, join this Choice Agenda ([link removed]) webinar discussing potential responses through the lens of HIV affected communities and programs.
Register Now ([link removed]) [link removed]
WEBINAR
Thursday, July 11, 9:00AM ET
[link removed]
** You Get What You Measure: Why Monitoring for PrEP Choice Helps Tell Our Story ([link removed])
------------------------------------------------------------
The data collected on a program determines its path and priorities. This Choice Agenda ([link removed]) webinar will cover the current state of PrEP monitoring and evaluation, and efforts to improve and simplify data-gathering to better reflect how people use PrEP and to support choice amongst the growing array of PrEP methods. And the discussion will also focus on how data can be used to enhance the stories we tell about PrEP program implementation.
Register Now ([link removed]) [link removed]
Recordings and Resources
archived Webinar
[link removed]
** From The Lab To The Jab Webinar and Issue Briefs ([link removed])
------------------------------------------------------------
Earlier this month, AVAC hosted a webinar ([link removed]) highlighting our series of issue briefs, From The Lab To The Jab ([link removed]) , covering research and development, mRNA technology, vaccine production, issues relevant to equitable global access to vaccines. The webinar featured panelists from the International Vaccine Institute ([link removed]) , International Treatment Preparedness Coalition ([link removed]) , and æqua, a think tank focused on equity and economic justice for health. Panelists discussed international initiatives for vaccine development, the current state of vaccine research and access, and how they can be improved.
read more ([link removed])
archived WEBINAR
[link removed]
** The GPP Body of Evidence: GPP Monitoring and Evaluation Frameworks, REAL and REAL2 ([link removed])
------------------------------------------------------------
GPP is an essential part of clinical trials research, and an ethical imperative to creating equitable and effective clinical trials. GPP is created by and for communities, so it looks different and takes multiple forms in different cultural contexts. This kind of responsiveness is inherent to GPP, but it also makes it difficult to measure and evaluate. In this webinar, participants will learn from the Realist Review of Community Engagement and the REAL2 review of participatory research. Each examined frameworks for evaluating community engagement efforts. We’ll also learn about the Global Health Network’s new course on evaluation, and other efforts in the field to evaluate the impact of GPP.
v ([link removed]) iew the recording [link removed]
ARCHIVED WEBINAR
[link removed]
** It’s Not Just about the Trial: GPP from discovery to delivery in TB research ([link removed])
------------------------------------------------------------
GPP enhances every stage of the research lifecycle. In this webinar, our partners at TB Alliance ([link removed]) , SMART4TB ([link removed]) , and THINK ([link removed]) shared experiences, lessons learned, and innovative approaches in integrating GPP at the organizational, network and situational level, from drug development through delivery.
View the recording [link removed]
ADVOCATES' GUIDE
[link removed]
**
------------------------------------------------------------
Advocates’ Guide to Doxycycline to Prevent Bacterial STIs (DoxyPEP) ([link removed])
Doxycycline, an oral antibiotic, can be used as a post-exposure prophylaxis, commonly referred to as DoxyPEP, when used to prevent the acquisition of some bacterial STIs after sex. Doxycycline is inexpensive, easily tolerated, and widely available. However, questions remain regarding who will benefit most from DoxyPEP and how to implement this strategy broadly to ensure equitable access and minimize antimicrobial resistance. This guide seeks to explore and address these critical questions.
r ([link removed]) ead the guide [link removed]
podcast
[link removed]
** Episode 3: The Promising Science ([link removed])
------------------------------------------------------------
Our Mitchell Warren ([link removed]) speaks to ViiV's Kimberly Smith ([link removed]) in this episode of the Foreign Policy ([link removed]) podcast series ‘can we end epidemics?’ about the future of HIV science and the challenges we need to overcome on our journey to finding a cure.
l ([link removed]) isten [link removed]
We hope these conversations and resources are helpful in your advocacy. Stay tuned for our upcoming advocates’ primer on lenacapavir ([link removed]) and our roadmap to the AIDS 2024 conference in Munich.
Best,
AVAC
Follow us @hivpxresearch ([link removed])
[link removed] [link removed] [link removed]
Share this issue ([link removed]) [link removed]
AVAC Global Advocacy for HIV Prevention
+1 212 796 6423
[email protected] (mailto:
[email protected]) www.avac.org ([link removed])
You're receiving this because you signed up for our newsletter. Not interested any longer?
Manage email preferences ([link removed]) | Unsubscribe ([link removed])
